Kalaris Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Kalaris Therapeutics, Inc.
CIK #0001754068
EDGAR Form CIK 2011 - 2025
10-K [0001754068]
10-Q [0001754068]
3 [0001754068]
4 [0001754068]
5 [0001754068]
8-K [0001754068]
D [0001754068]
SC 13D [0001754068]
SC 13G [0001754068]
Form 13D/13G Filer Form 13D/13G Subject Filed
Samsara Biocapital LP Kalaris Therapeutics Inc [2025-03-25]
Octagon Capital Advisors LP Allovir Inc [2024-10-11]
EcoR1 Capital LLC Allovir Inc [2024-02-01]
Wilson John Robert Allovir Inc [2024-01-09]
Gilead Sciences Inc Allovir Inc [2022-08-08]
Globeways Holdings II Ltd Allovir Inc [2022-08-05]
Artal International SCA Allovir Inc [2022-08-05]
Globeways Holdings II Ltd Allovir Inc [2020-08-13]
Elevatebio LLC Allovir Inc [2020-08-13]
FMR LLC Allovir Inc [2020-08-10]
Form 3/4/5 Subject 2011 - 2025
Patterson Leone D
Kalaris Therapeutics, Inc.
Hallal David
Hagen Brett R
Akkaraju Srinivas
Jovan-Embiricos Morana
Patel Samir Chandrakant
Ferrara Napoleone
Dybbs Michael
Oxtoby Andrew
View All
Terms | Privacy | Guide
tony@aum13f.com